InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,744.80
(
0.00%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
71.36
(
1.19%
)
Bitcoin
58,264.57
(
1.60%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Thursday, 01/20/2011 8:40:16 AM

Thursday, January 20, 2011 8:40:16 AM

Post# of 92948
jon,


"rock, what is your take on SMD trial delay? are you concerned?"

jon, info would dictate there is a delay. December Executive Summary stated protocol was approved and trial sites were designated with patient treatment in first quarter.
http://www.thechairmansblog.com/william-caldwell/wp-content/uploads/2010/12/Executive-Summary-ACT-Macular-Degeneartion-Program.pdf

January 3 PR had stated info to be on clinicaltrials.gov, "shortly"

Mid January Corp. Presentation, "IND approved Nov. 2010
Phase I to begin 1st Half 2011"

I was here when Myoblast Phase 2 was suppose to be on the verge of starting with all clinics in place as well as supplier partnerships and all info submitted to clinicaltrials.gov and 3 years later..nothing..so yes, delays are an inherited concern with ACT..
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up